background an increased risk of breast cancer is associated with alcohol consumption however it is controversial whether red wine increases this riskaromatase inhibitors ais prevent the conversion of androgens to estrogen and occur naturally in grapes grape juice and red but not white winewe tested whether red wine is a nutritional ai in premenopausal womenmethods in a crossover design 36 women mean age sd 36 8 years were assigned to 8 ounces 237 ml of red wine daily then white wine for 1 month each or the reverseblood was collected twice during the menstrual cycle for measurement of estradiol e2 estrone e1 androstenedione a total and free testosterone t sex hormone binding globulin shbg luteinizing hormone lh and follicle stimulating hormone fshresults red wine demonstrated higher free t vs white wine mean difference 064 pgml 02 se p0009 and lower shbg mean difference 50 nmoll 19 se p0007e2 levels were lower in red vs white wine but not statistically significantlh was significantly higher in red vs white wine mean difference 23 miuml 13 se p0027 however fsh was notconclusion red wine is associated with significantly higher free t and lower shbg levels as well as a significant higher lh level vs white wine in healthy premenopausal womenthese data suggest that red wine is a nutritional ai and may explain the observation that red wine does not appear to increase breast cancer risk